Brendt Stier, a pharmacologist, spent most of 2020 developing Moderna’s COVID-19 clinical trials prior to the December 2020 vaccine roll-out. “It’s been a great experience to learn so much about the virus and to find innovative ways to help our clients treat or prevent the COVID-19 virus,” says Stier, senior director of value and development consulting with PPD, Moderna’s strategic development partner. “Every day I’m reading scientific journals, textbooks, etc. to learn about the latest trends or therapies for a particular disease.”
When it came time to choose the best educational option for their son, Stier and his wife Liz wanted a school that embraced their passion for lifelong learning. Like many parents, they did their research. “We explored the public school system because we wanted to see what they had to offer and quickly realized that the larger class sizes and multiple grade levels really wasn’t what we were looking for,” Stier explains.
READ FULL ARTICLE HERE
